During the past decade, Los Angeles Hematology/Oncology Medical Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Los Angeles Hematology/Oncology Medical Group" #1 collaborator was "Medivation, Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Los Angeles Hematology/Oncology Medical Group" are "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Los Angeles Hematology/Oncology Medical Group" in a lesser frequency.

Most popular intervention types in "Los Angeles Hematology/Oncology Medical Group" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Axitinib (AG-013736)" (1 trials), "Letrozole" (1 trials), "MabThera®" (1 trials) and "PD-0332991" (1 trials). Other intervention names were less common.

The vast majority of trials in "Los Angeles Hematology/Oncology Medical Group" are 3 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Los Angeles Hematology/Oncology Medical Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Los Angeles Hematology/Oncology Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Los Angeles Hematology/Oncology Medical Group, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".